5.1.3 Tetracyclines

Doxycycline
  • Capsules 50mg (£2.17 = 28 pack), 100mg (£1.35 = 8 pack)
  • Dispersible tablets 100mg (£4.91 = 8 dispersible tablets)

Indications

Notes

  1. COVID-19: Doxycycline should NOT be used in the management of confirmed or suspected COVID-19 infection within primary care, unless there are additional indications for which its use remains appropriate. For more information, see the CAS alert (issued 28 January 2021)
  2. Dispersible tablets are considerably more expensive than capsules and should be reserved for use only in individuals who are unable to swallow capsules
Lymecycline
  • Capsules 408mg (£8.64 = 28 capsules)

Indications

Oxytetracycline
  • Tablets 250mg (£5.12 = 28 tablets)

Indications

Demeclocycline hydrochloride
  • Capsules 150mg (£238.41 = 28 capsules)

Notes

  1. Demeclocycline is not used for the treatment of infection, but is used in the management of inappropriate secretion of antidiuretic hormone.
Minocycline

Following national guidance from NHS England, minocycline is not recommended for use for the treatment of acne due to an increased risk of adverse effects such as drug induced lupus, skin pigmentation and hepatitis. Click here for more information. Prescribers should not initiate minocycline for acne for any new patient.

Last updated: 21-05-2021

 

Home > Formulary > Chapters > 5. Infections > 5.1 Antibacterial drugs > 5.1.3 Tetracyclines

 

  • First line
  • Second line
  • Specialist
  • Hospital